DOPAMIN-ANTAGONISTE

DOPAMIN-ANTAGONISTE

Compounds are disclosed having the formula: wherein: R1 is H, OH, -OCH3, -CH2OH, -NH2, -NHMe, -NHEt, -NMe2, -NEt2, R2 is H, -CH3, or R3 is phenyl, benzyl, or 1-4 carbon alkyl; R4 is H, -CH3, -CH2OH, -CH2-CN, -CH2-S-Me, CH2-S-CN, or R5 is H, 1-4 carbon alkyl, alkenyl, or alkynyl, or aralkyl having a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: HORN, S., ALAN, NL-NOORDHORN, NL
Format: Patent
Sprache:ger
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Compounds are disclosed having the formula: wherein: R1 is H, OH, -OCH3, -CH2OH, -NH2, -NHMe, -NHEt, -NMe2, -NEt2, R2 is H, -CH3, or R3 is phenyl, benzyl, or 1-4 carbon alkyl; R4 is H, -CH3, -CH2OH, -CH2-CN, -CH2-S-Me, CH2-S-CN, or R5 is H, 1-4 carbon alkyl, alkenyl, or alkynyl, or aralkyl having a 1-4 carbon alkylene moiety; and A is -CH2-or -CH2CH2-, and pharmaceutically-acceptable salts thereof. Pharmaceutical preparations using these compounds and a method for inducing a dopaminergic response by administering these compounds are also disclosed.